In a surprise reveal that propelled stocks by 25%, Alteogen Inc., of Daejeon, South Korea, named MSD International Business GmbH as its counterpart in a near-$4 billion technology transfer agreement ...
MSD The Main Partner of the 17th International Breast and Gynaecological Cancer Conference to Support Women's Health and Raise Awareness of Breast Cancer Risks emphasized that the company's ...
The Chosun Ilbo on MSN
MSD Korea CEO stresses science, R&D leadership
MSD is a company that is ‘serious about science.’ In 2024, its global research and development investment reached $17.9 ...
Lund, Sweden - July 17, 2024 - BioInvent International AB ("BioInvent") (Nasdaq Stockholm: BINV), a biotech company focused on the discovery and development of novel and first-in-class ...
A Merck KGaA brand logo stands in front of the company premises. WuXi Biologics, a Chinese biopharmaceuticals company, announced on 06 January the sale of its WuXi Vaccines facility in Ireland to MSD ...
MSD Ireland (tradename of Merck & Co., Inc., Rahway, N.J., USA (NYSE: MRK)) has today announced the official opening of its new solar project at Ballydine, Co Tipperary. The development is Ireland’s ...
Agreement covers Phase 1/2a trial with TNFR2 agonist antibody BI-1910 First data from BI-1910 single agent arm expected by YE 2024 LUND, SWEDEN / ACCESSWIRE / April 2, 2024 / BioInvent International ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback